Total trials
91
Active
1
Phase 3
46
Total enrollment
83,302
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| prednisolone | — | — | — | — | — | 4 | |
| docetaxel | — | — | — | — | — | 2 | |
| Celecoxib | — | — | — | — | — | 1 | |
| ADT | — | — | — | — | — | 1 | |
| Zoledronic Acid | — | — | — | — | — | 1 | |
| Abiraterone | — | — | — | — | — | 1 | |
| Enzalutamide | — | — | — | — | — | 1 | |
| Metformin | — | — | — | — | — | 1 | |
| Transdermal Oestradiol | — | — | — | — | — | 1 |
Next readouts
- 2026-03
Top conditions
- Colorectal Cancer7
- Ovarian Cancer7
- Leukemia6
- Testicular Germ Cell Tumor5
- Breast Cancer4
- Lung Cancer4
- Major Depressive Disorder4
- HIV Infections4
Frequently asked questions about Medical Research Council
- How many clinical trials does Medical Research Council have on ClinicalTrials.gov?
- Medical Research Council is listed as the lead sponsor on 91 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical Research Council's trials are in Phase 3?
- 46 of Medical Research Council's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does Medical Research Council focus on?
- Medical Research Council's most-studied conditions on ClinicalTrials.gov are Colorectal Cancer, Ovarian Cancer, Leukemia, Testicular Germ Cell Tumor, Breast Cancer.
- When are Medical Research Council's next clinical trial readouts?
- Medical Research Council has 1 upcoming primary-completion readout tracked here; the soonest is “Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy”, expected around 2026-03.